NEW YORK ( TheStreet) -- Here are 10 things you should know for Monday, April 1:
1. -- U.S. stock futures were slightly lower on Monday ahead of the Institute for Supply Management's manufacturing survey for March.
European markets were closed Monday.
Japan's Nikkei 225 index fell 2.1% after a central bank survey showed a smaller-than-expected improvement in business sentiment.
2. -- The economic calendar in the U.S. Monday includes the ISm Index for March at 10 a.m. EDT, and construction spending and factory orders for February at 10 a.m.
3. -- U.S. stocks on Thursday finished with gains and the S&P 500 reached a record closing high on the final trading day of the quarter. The S&P 500 climbed 0.4% to close at 1569.19, trumping its former record of 1,565.15 reached on Oct. 9, 2007. The Dow Jones Industrial Average gained 0.36% to 14,578.54. The Nasdaq added 0.34% to 3,267.52. U.S. markets were closed Friday.
4. -- BlackBerry (BBRY - Get Report) shares slipped 0.8% on Thursday to $14.44 despite surprising Wall Street with a fourth-quarter profit. The smartphone maker earned 22 cents a share on revenue of $2.7 billion during the quarter. Analysts were looking for BlackBerry, formerly known as Research In Motion, to lose 29 cents a share on revenue of $2.84 billion. The company said it shipped 6 million BlackBerry smartphones, including 1 million BlackBerry 10 smartphones and 370,000 PlayBook tablets, during the quarter. BlackBerry shares rose 22% in the first quarter.
5. -- Dell (DELL - Get Report) founder Michael Dell will only consider backing a buyout by Blackstone Group (BX) if the private-equity firm guarantees he can remain as CEO, Bloomberg reported, citing a person familiar with the discussions.
6. -- Analog Devices (ADI - Get Report) said CEO Jerald Fishman, 67, died following an apparent heart attack Thursday night. The chipmaker said Friday that President Vincent Roche has been appointed CEO on an interim basis.
7. -- India's Supreme Court on Monday rejected Novartis' (NVS - Get Report) attempt to patent an updated version of cancer drug Glivec. Novartis argued that it needed a patent to protect its investment in the drug while activists said the drug didn't merit intellectual property protection in India because it was not a new medicine, The Associated Press reported.
8. -- Michael Steinberg, a senior portfolio manager for SAC Capital Advisors, was arrested Friday, accused of joining an insider trading conspiracy that the government said made more than $6 million illegally for the investment company founded by businessman Steven A. Cohen. Steinberg pleaded not guilty Friday to the insider trading charges.